Treprostinil
These highlights do not include all the information needed to use TREPROSTINIL INJECTION safely and effectively. See full prescribing information for TREPROSTINIL INJECTION. TREPROSTINIL injection, for subcutaneous or intravenous use Initial U.S. Approval: May 2002
4a684b13-669d-4721-8ed4-30cc7762b0b8
HUMAN PRESCRIPTION DRUG LABEL
Jan 25, 2023
Alembic Pharmaceuticals Inc.
DUNS: 079288842
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Treprostinil
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Treprostinil
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Treprostinil
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Treprostinil
Product Details
FDA regulatory identification and product classification information